4//SEC Filing
Gibbs Michael Terrence 4
Accession 0000950170-25-000592
CIK 0001492674other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 6:20 PM ET
Size
7.9 KB
Accession
0000950170-25-000592
Insider Transaction Report
Form 4
Gibbs Michael Terrence
General Counsel
Transactions
- Award
Restricted Stock Units
2024-11-04+190,000→ 190,000 total→ Common Stock (190,000 underlying) - Award
Restricted Stock Units
2024-11-04+190,000→ 190,000 total→ Common Stock (190,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On November 4, 2024, the reporting person was granted 190,000 RSU's that vest in one installment on May 4, 2025. This grant was contingent on stockholder approval of the amendment and restatement of Issuer's 2014 Incentive Award Plan. The Issuer's stockholders approved the amendment and restatement of the plan on December 30, 2024.
- [F3]On November 4, 2024, the reporting person was granted 190,000 RSU's that vest in three equal annual installments beginning on November 4, 2025. This grant was contingent on stockholder approval of the amendment and restatement of Issuer's 2014 Incentive Award Plan. The Issuer's stockholders approved the amendment and restatement of the plan on December 30, 2024.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001665000
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 6:20 PM ET
- Size
- 7.9 KB